Approach to Quality Control Used for the HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis
- PMID: 41414940
- DOI: 10.2215/CJN.0000000970
Approach to Quality Control Used for the HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis
Keywords: ESKD; hyperphosphatemia; vascular calcification.
References
-
- Strippoli GF, Craig JC, Schena FP. The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol. 2004;15(2):411–419. doi:10.1097/01.ASN.0000100125.21491.46 - DOI
-
- Inrig JK, Califf RM, Tasneem A, et al. The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov. Am J Kidney Dis. 2014;63(5):771–780. doi:10.1053/j.ajkd.2013.10.043 - DOI
-
- Dember LM, Hsu JY, Mehrotra R, et al. Pain coping skills training for patients receiving hemodialysis: the HOPE consortium randomized clinical trial. JAMA Intern Med. 2025;185(2):197–207. doi:10.1001/jamainternmed.2024.7140 - DOI
-
- Dember LM, Hsu JY, Bernardo L, et al. The design and baseline characteristics for the HOPE Consortium Trial to reduce pain and opioid use in hemodialysis. Contemp Clin Trials. 2024;136:107409. doi:10.1016/j.cct.2023.107409 - DOI
-
- Mehrotra R, Cukor D, McCurry SM, et al. Effectiveness of existing insomnia therapies for patients undergoing hemodialysis: a randomized clinical trial. Ann Intern Med. 2024;177(2):177–188. doi:10.7326/M23-1794 - DOI
Grants and funding
LinkOut - more resources
Full Text Sources
